DD298478A5 - Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen - Google Patents

Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen Download PDF

Info

Publication number
DD298478A5
DD298478A5 DD90344383A DD34438390A DD298478A5 DD 298478 A5 DD298478 A5 DD 298478A5 DD 90344383 A DD90344383 A DD 90344383A DD 34438390 A DD34438390 A DD 34438390A DD 298478 A5 DD298478 A5 DD 298478A5
Authority
DD
German Democratic Republic
Prior art keywords
phenyl
group
alkyl
oxo
cyano
Prior art date
Application number
DD90344383A
Other languages
German (de)
English (en)
Inventor
Gianfederico Doria
Anna M Isetta
Rinaldo Ferreccio
Mario Ferrari
Maria C Fornasiero
Domenico Trizio
Original Assignee
����������@�����@����@�K�K�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����������@�����@����@�K�K�Kk�� filed Critical ����������@�����@����@�K�K�Kk��
Publication of DD298478A5 publication Critical patent/DD298478A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD90344383A 1989-04-06 1990-10-02 Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen DD298478A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898907799A GB8907799D0 (en) 1989-04-06 1989-04-06 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases

Publications (1)

Publication Number Publication Date
DD298478A5 true DD298478A5 (de) 1992-02-27

Family

ID=10654581

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90344383A DD298478A5 (de) 1989-04-06 1990-10-02 Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen

Country Status (15)

Country Link
US (2) US5196445A (pt)
EP (1) EP0423269B1 (pt)
JP (1) JPH03505332A (pt)
KR (1) KR920700031A (pt)
AT (1) ATE99934T1 (pt)
AU (1) AU5416990A (pt)
CA (1) CA2030530A1 (pt)
DD (1) DD298478A5 (pt)
DE (1) DE69005974T2 (pt)
GB (1) GB8907799D0 (pt)
HU (1) HUT58518A (pt)
IL (1) IL93989A0 (pt)
PT (1) PT93680A (pt)
WO (1) WO1990011760A1 (pt)
ZA (1) ZA902649B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU698990B2 (en) * 1993-04-09 1998-11-19 Toyama Chemical Co. Ltd. Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
US6211147B1 (en) * 1995-08-15 2001-04-03 Connetics Corporation Method of promoting angiogenesis using relaxin
US7285422B1 (en) * 1997-01-23 2007-10-23 Sequenom, Inc. Systems and methods for preparing and analyzing low volume analyte array elements
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
GB9720901D0 (en) * 1997-10-01 1997-12-03 Pharmacia & Upjohn Spa Condensed benzothiopyranic compounds
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
WO2002100334A2 (en) * 2001-06-11 2002-12-19 University Of Miami Use of radiopharmaceutical complexes in achieving transplantation tolerance
JP2005506983A (ja) * 2001-09-19 2005-03-10 ファルマシア・コーポレーション 炎症の治療のための置換ピラゾリル化合物
WO2003024936A1 (en) * 2001-09-19 2003-03-27 Pharmacia Corporation Substituted pyrazolo compounds for the treatment of inflammation
US20050116027A1 (en) * 2003-06-12 2005-06-02 First Data Corp. Personalized presentation instrument production systems and methods
US9073940B2 (en) * 2009-11-13 2015-07-07 Merck Serono Sa Tricyclic pyrazol amine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4173634A (en) * 1979-02-23 1979-11-06 E. R. Squibb & Sons, Inc. Basically-substituted tricyclic pyrazoles useful as antiinflammatory agents
JPS57109787A (en) * 1980-12-26 1982-07-08 Chugai Pharmaceut Co Ltd Pyrazoloindazole derivative
US4816467A (en) * 1987-01-09 1989-03-28 Farmitalia Carlo Erba S.R.L Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
IL85110A (en) * 1987-01-21 1991-12-12 Erba Carlo Spa Condensed pyrazole derivatives,their preparation and pharmaceutical compositions containing them
GB8814586D0 (en) * 1988-06-20 1988-07-27 Erba Carlo Spa Tricyclic 3-oxo-propanenitrile derivatives & process for their preparation
GB8814587D0 (en) * 1988-06-20 1988-07-27 Erba Carlo Spa Condensed pyrazole 3-oxo-propanenitrile derivatives & process for their preparation
PH26314A (en) * 1988-08-09 1994-04-29 Boots Co Plc Benzopyrano [4,3-c] pyrazoles derivatives
GB2227741B (en) * 1989-02-06 1992-08-05 Erba Carlo Spa Condensed 3-oxo-propanenitrile derivatives and process for their preparation

Also Published As

Publication number Publication date
DE69005974D1 (de) 1994-02-24
HU903690D0 (en) 1991-03-28
EP0423269B1 (en) 1994-01-12
ZA902649B (en) 1991-01-30
PT93680A (pt) 1990-11-20
CA2030530A1 (en) 1990-10-07
KR920700031A (ko) 1992-02-19
GB8907799D0 (en) 1989-05-17
AU5416990A (en) 1990-11-05
IL93989A0 (en) 1991-01-31
HUT58518A (en) 1992-03-30
US5352676A (en) 1994-10-04
WO1990011760A1 (en) 1990-10-18
ATE99934T1 (de) 1994-01-15
DE69005974T2 (de) 1994-05-05
US5196445A (en) 1993-03-23
EP0423269A1 (en) 1991-04-24
JPH03505332A (ja) 1991-11-21

Similar Documents

Publication Publication Date Title
DE69309094T2 (de) Hemmung der TNF - Bildung
DE3876400T2 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
DE69435021T2 (de) Kombination eines Angiotensin-II antagonistisch wirkenden Benzimidazols mit einem Diuretikum
DE69725345T2 (de) Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
DE3740351A1 (de) Pharmazeutisches praeparat
JPH08505378A (ja) パーキンソン病およびパーキンソン病症候群の治療におけるリルゾールの用途
DD298478A5 (de) Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen
DE3780940T2 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
DE3782028T2 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE69009717T2 (de) Heteroaryl-3-oxo-propan-nitril-derivat verwendbar in erregung von myelopoiesis.
DE69108067T2 (de) Thiazolidin-Derivate mit antihypertensiver Aktivität und deren therapeutische Anwendung.
DD273258A5 (de) Verfahren zur herstellung von spiroimidazolidinen
DE69026016T2 (de) Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes
EP0412901A2 (fr) Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale
US5260328A (en) Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis
GB2244431A (en) Treatment of age related memory impairment and other cognitive disorders
DE69023964T2 (de) Verwendung von Isoxazolin-3-one-Derivaten als Antidepressiva.
DE68915595T2 (de) Verwendung von Isoxazolinonen als cerebro-aktive Medikamente.
EP0508955A1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
DE69822846T2 (de) Medikament zur Behandlung des Reizkolons
DE3887426T2 (de) Eperisone als Hypotonikum.
DE69302250T2 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
DE69532963T2 (de) Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen
DE1695532A1 (de) Chinoxalinverbindungen sowie Verfahren zu deren Herstellung
DE602004008960T2 (de) Verwendung von 1-thiadibenzo e,h azulenen zur herstellung von pharmazeutischen formulierungen für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems

Legal Events

Date Code Title Description
WP12 As result of examination under paragraph 12 erstrg. patent revoked